AccuFFRangio is a software system for fractional flow reserve (FFR) analysis in coronary angiography. It enables non-invasive assessment of coronary stenosis severity from angiographic images, supporting cardiologists in clinical decision-making for percutaneous coronary intervention.
Manufactured by
Hangzhou ArteryFlow Technology Co., Ltd.
China
Hangzhou ArteryFlow Technology, founded in 2017, is a national high-tech enterprise providing intelligent cardiovascular and cerebrovascular disease solutions globally. The company leverages medical big data, computational simulation, hemodynamics, and AI algorithms to deliver platform-based products covering screening, detection, diagnosis, and precision surgery across hospital and outpatient settings.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Shenzhen Escope Tech Co., Ltd.
China · 3 relevant products
Hangzhou Shengshi Technology Co., Ltd.
China · 2 relevant products
APlus Healthcare Technology (Shanghai) Co., Ltd
China · 1 relevant product
28 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →12 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 39 closest product alternatives
Shenzhen Escope Tech Co., Ltd. · China
CoroScope CT-FFR is an AI-powered imaging analysis platform for coronary artery assessment and fractional flow reserve (FFR) computation from CT angiography. It integrates machine learning and computational fluid dynamics to enable non-invasive functional evaluation of coronary stenosis, supporting clinical decision-making in cardiology.
Hangzhou Shengshi Technology Co., Ltd. · China
Software platform for non-invasive assessment of coronary artery fractional flow reserve using computational fluid dynamics and artificial intelligence. Enables precise diagnosis of coronary artery disease severity to guide interventional cardiology decisions. Integrates fluid dynamics simulation with clinical imaging data for quantitative hemodynamic analysis.
Hangzhou Shengshi Technology Co., Ltd. · China
Software that performs quantitative analysis and numerical simulation of coronary CTA images using CFD computational fluid dynamics and AI medical imaging technologies to obtain FFR values, assisting physicians in functional assessment and clinical diagnosis of coronary artery disease.
36 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products